Viatris sank -6.0% this afternoon, compared to the S&P 500's day change of -1.0%. Today's losers may turn out to be tomorrow's winners, so be sure to check the stock's fundamentals before making an investment decision:
-
Viatris has logged a 5.0% 52 week change, compared to 13.0% for the S&P 500
-
VTRS has an average analyst rating of hold and is -36.06% away from its mean target price of $14.78 per share
-
Its trailing earnings per share (EPS) is $1.53, which brings its trailing Price to Earnings (P/E) ratio to 6.2. The Health Care sector's average P/E ratio is 24.45
-
The company's forward earnings per share (EPS) is $2.87 and its forward P/E ratio is 3.3
-
The company has a Price to Book (P/B) ratio of 0.54 in contrast to the Health Care sector's average P/B ratio is 4.16
-
The current ratio is currently 1.6, which consists in its liquid assets divided by any liabilities due within in the next 12 months
-
VTRS has reported YOY quarterly earnings growth of -15.0% and gross profit margins of 0.4%
-
The company's free cash flow for the last fiscal year was $1.39 Billion and the average free cash flow growth rate is 0.0%
-
Viatris's revenues have an average growth rate of 0.0% with operating expenses growing at -7.9%. The company's current operating margins stand at 10.2%